Related Experiment Video

Updated: Jun 14, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.4K

Rosuvastatin-Induced Myopathy: A Case Series

Susheel K Malani1, Sridevi Chigullapalli1, Saurabh Sujanyal2

  • 1Cardiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pune (Deemed to Be University), Pune, IND.

Cureus
|September 5, 2024
PubMed
Summary

Rosuvastatin can cause severe myopathy, kidney, and liver injury, even in patients without vitamin D deficiency. Stopping the drug and switching to alternatives resolved symptoms, highlighting the need for increased pharmacovigilance.

Keywords:
acute kidney injuryacute liver injuryrosuvastatinstatin-induced myopathyvitamin d deficiency

More Related Videos

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

3.3K
Functional Characterization of Endogenously Expressed Human RYR1 Variants07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

2.5K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K